Frontline hyper-CVAD plus ponatinib for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: Updated results of a phase II study. This is an ASCO Meeting Abstract from the 2017 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results